布地奈德联合阿奇霉素治疗小儿肺炎支原体肺炎的临床效果

Clinical Effect of Budesonide Combined with Azithromycin in Treatment of Mycoplasmal Pneumoniae Pneumonia in Children

目的:分析布地奈德联合阿奇霉素治疗小儿肺炎支原体肺炎的临床效果。方法:选取2022年1—12月宝应县妇幼保健院收治的肺炎支原体肺炎患儿120例为研究对象,采用随机抽签法分为观察组(61例)和对照组(59例)。对照组给予阿奇霉素治疗,观察组给予阿奇霉素联合布地奈德治疗。比较两组患儿治疗效果。结果:观察组临床疗效优于对照组,差异有统计学意义(P<0.001);观察组发热、喘息、咳嗽、肺部啰音恢复时间和住院时间均短于对照组,差异有统计学意义(P<0.001);两组不良反应总发生率比较,差异无统计学意义(P>0.05)。结论:布地奈德联合阿奇霉素治疗小儿肺炎支原体肺炎效果显著,可缩短恢复时间,不会增加不良反应。

Objective:To analyze the clinical effect of budesonide combined with azithromycin in the treatment of mycoplasmal pneumoniae pneumonia in children.Methods:A total of 120 children with Mycoplasma pneumoniae pneumonia at Baoying County Maternal and Child Health Hospital from January to December 2022 were selected as the study subjects.They were divided into an observation group(61 cases)and a control group(59 cases)using a random drawing method.The control group was treated with azithromycin and the observation group was treated with azithromycin and budesonide.The therapeutic effects of the two groups were compared.Results:The clinical efficacy in the observation group was better than that in the control group,with a statistically significant difference(P<0.001).The recovery time of fever,wheezing,cough and pulmonary rales in the observation group was shorter than that in the control group,and the difference was statistically significant(P<0.001).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:The efficacy of budesonide combined with azithromycin in the treatment of children with mycoplasmal pneumoniae pneumonia is significant,which can shorten the recovery time and will not increase adverse reactions.